Pfizer CentreOne CPhI Barcelona Pfizer CentreOne CPhI Barcelona

X

Find the latest Drugs in Development and Pipeline Prospector News of Prague Scientific.

  • Webinars & Exhibitions

  • Agomelatine

  • Elvitegravir

  • Ivacaftor

  • Ramipril

  • Sacubitril Sodium

  • Tenofovir Alafenamide

  • Vortioxetine

  • Vortioxetine Hydrobromide

  • Route Scouting Services

  • API Process Development & Optimization

  • Oligonucleotide Synthesis

  • GMP Operations for Commercial Manufacturing

  • Formulation Development of Tablets

  • Suspension Contract Manufacturing

PharmaCompass
Zentiva VB RM
Prague Scientific
CzechRepublic Flag
Country
Country
Czech Republic
Address
Address
U Kabelovny 529/16 102 00 Prague 10
Telephone
Telephone
+420 267 243 231
Twitter
Twitter
Contact Info
Others

Details:

Rivaroxaban oral suspension, inhibits free FXa and prothrombinase activity. It has no direct effect on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin. By inhibiting FXa, it decreases thrombin generation.


Lead Product(s): Rivaroxaban

Therapeutic Area: Cardiology/Vascular Diseases Product Name: Rivaroxaban-Generic

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 10, 2023

Details:

Omeprazole magnesium is a proton-pump inhibitor, used to treat gastric acid-related disorders. These disorders may include gastroesophageal reflux disease (GERD), peptic ulcer disease, and other diseases characterized by the oversecretion of gastric acid.


Lead Product(s): Omeprazole Magnesium

Therapeutic Area: Gastroenterology Product Name: Omeprazole Magnesium-Generic

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable November 25, 2022

Details:

Finasteride and tadalafil combination is used to treat men with benign prostatic hyperplasia (BPH). Tadalafil is a PDE5 inhibitor and finasteride blocks the action of 5-alpha-reductase which will increase testosterone levels in the body, which decreases prostate size.


Lead Product(s): Finasteride,Tadalafil

Therapeutic Area: Urology Product Name: Finasteride/Tadalafil-Generic

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 26, 2021

Details:

Sitagliptin is a DPP-4 inhibitor, which is believed to exert its actions in patients with type 2 diabetes by slowing the inactivation of incretin hormones.


Lead Product(s): Sitagliptin Phosphate

Therapeutic Area: Endocrinology Product Name: Sitagliptin-Generic

Highest Development Status: Phase IIIProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 12, 2021

Details:

Sertraline hydrochloride potentiates serotonergic activity in the central nervous system through inhibition of neuronal reuptake of serotonin (5-HT). It is indicated for the treatment of MDD, PTSD, PMDD, panic disorder, and social anxiety disorder.


Lead Product(s): Sertraline Hydrochloride

Therapeutic Area: Psychiatry/Psychology Product Name: Sertraline Hydrochloride-Generic

Highest Development Status: Phase IIIProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 12, 2021

Details:

Sacubitril and Valsartan drug inhibits neprilysin and blocks angiotensin II type-I receptor, increasing the levels of peptides degraded by neprilysin. It is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure.


Lead Product(s): Sacubitril Sodium,Valsartan

Therapeutic Area: Cardiology/Vascular Diseases Product Name: Sacubitril/Valsartan-Generic

Highest Development Status: Phase IIIProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 01, 2021

Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY